U01.01.104 Pentose phosphate pathway

Learning Objectives

  • Identify the two primary products of the HMP shunt and their metabolic roles.
  • Distinguish between the oxidative (irreversible) and non-oxidative (reversible) phases.
  • Recognize the key tissues where this pathway is most active.
  • Explain the clinical importance of Vitamin B1 (Thiamine) in the non-oxidative phase.

1. Overview of the HMP Shunt

The Pentose Phosphate Pathway (HMP Shunt) occurs entirely in the cytoplasm. It functions as a bypass of glycolysis to produce essential specialized molecules. Importantly, no ATP is used or produced in this pathway.

  • NADPH: Used for reductive biosynthesis (fatty acids, steroids) and protecting cells against oxidative stress (reducing glutathione in RBCs).
  • Ribose-5-Phosphate: A critical precursor for nucleotide synthesis.


2. The Two Phases of the Pathway

The pathway is split into an energy-generating oxidative phase and a sugar-shuffling non-oxidative phase.

Oxidative Phase (Irreversible)

  • Rate-Limiting Enzyme: Glucose-6-phosphate dehydrogenase (G6PD).
  • Key Step: Glucose-6-P → 6-Phosphogluconate → Ribulose-5-P.
  • Yield: 2 NADPH and 1 CO_{2} per glucose molecule.

Non-oxidative Phase (Reversible)

  • Key Enzyme: Transketolase.
  • Cofactor: Requires Vitamin B1 (Thiamine).
  • Function: Interconverts Ribulose-5-P into Glycolytic intermediates (Fructose-6-P, Glyceraldehyde-3-P).

Activity


3. Metabolic Sites and Clinical Significance

The HMP shunt is most active in tissues that require high levels of NADPH or rapid cell division.

Tissue Site Requirement
RBCs NADPH is used to maintain reduced glutathione (prevents hemolysis).
Adrenal Cortex / Liver NADPH for steroid and fatty acid synthesis.
Lactating Mammary Glands NADPH for fatty acid synthesis (milk production).

High-Yield Point:

If a patient has a thiamine (B1) deficiency, Transketolase activity decreases. This is used clinically to diagnose thiamine deficiency by measuring RBC transketolase activity after adding B1.


Activity